We are live on ! Find out more
VRM

Vectors Research Management Portfolio holdings

AUM $383M
1-Year Est. Return 30.23%
This Fund
S&P 500
This Quarter Est. Return
+6.54%
1 Year Est. Return
+30.23%
3 Year Est. Return
+67.25%
5 Year Est. Return
+74.92%
10 Year Est. Return
AUM
$354M
AUM Growth
-$911K
Cap. Flow
-$285M
Cap. Flow %
-80.51%
Top 10 Hldgs %
41.9%
Holding
144
New
4
Increased
35
Reduced
77
Closed
12

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$96.5M
2
MSFT icon
Microsoft
MSFT
+$55.3M
3
RSP icon
Invesco S&P 500 Equal Weight ETF
RSP
+$40.4M
4
PG icon
Procter & Gamble
PG
+$35.4M
5
IBM icon
IBM
IBM
+$23.3M

Sector Composition

Rank Sector Weight
1 Technology 9.49%
2 Healthcare 6.71%
3 Industrials 5.49%
4 Energy 4.65%
5 Financials 3.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RF icon
101
Regions Financial
RF
$27.3B
$526K 0.15%
25,000
AGCO icon
102
AGCO
AGCO
$7.51B
$517K 0.15%
4,201
-262
-6% -$30.5K
IVV icon
103
iShares Core S&P 500 ETF
IVV
$900B
$495K 0.14%
941
-2
-0.2% -$1K
MO icon
104
Altria Group
MO
$114B
$452K 0.13%
10,371
-794
-7% -$32.9K
GS icon
105
Goldman Sachs
GS
$311B
$451K 0.13%
1,080
PZA icon
106
Invesco National AMT-Free Municipal Bond ETF
PZA
$4.25B
$428K 0.12%
+17,948
New +$430K
RIO icon
107
Rio Tinto
RIO
$161B
$425K 0.12%
6,674
+19
+0.3% +$1.27K
UAN icon
108
CVR Partners
UAN
$1.33B
$403K 0.11%
5,132
-413
-7% -$28.9K
INTC icon
109
Intel
INTC
$509B
$399K 0.11%
9,033
NUE icon
110
Nucor
NUE
$62.4B
$399K 0.11%
2,016
COP icon
111
ConocoPhillips
COP
$144B
$398K 0.11%
3,130
-1,203
-28% -$137K
OKTA icon
112
Okta
OKTA
$25.7B
$390K 0.11%
3,728
-152
-4% -$14K
VOT icon
113
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$20B
$372K 0.11%
1,578
-258
-14% -$57.8K
PFE icon
114
Pfizer
PFE
$145B
$340K 0.1%
12,235
+200
+2% +$5.55K
SCHG icon
115
Schwab US Large-Cap Growth ETF
SCHG
$62.3B
$327K 0.09%
14,100
-1,900
-12% -$42K
KRE icon
116
State Street SPDR S&P Regional Banking ETF
KRE
$4.74B
$283K 0.08%
5,626
-39
-0.7% -$1.93K
HPQ icon
117
HP
HPQ
$26.4B
$272K 0.08%
9,000
-63
-0.7% -$1.85K
WM icon
118
Waste Management
WM
$90B
$271K 0.08%
1,270
+16
+1% +$3.14K
KMB icon
119
Kimberly-Clark
KMB
$37B
$265K 0.07%
2,048
SPHQ icon
120
Invesco S&P 500 Quality ETF
SPHQ
$20B
$261K 0.07%
4,312
ABBV icon
121
AbbVie
ABBV
$431B
$257K 0.07%
1,411
-255
-15% -$43.9K
PG icon
122
Procter & Gamble
PG
$345B
$257K 0.07%
1,253
-225,604
-99% -$35.4M
UNP icon
123
Union Pacific
UNP
$176B
$253K 0.07%
1,028
-79
-7% -$19.4K
KBE icon
124
State Street SPDR S&P Bank ETF
KBE
$1.69B
$249K 0.07%
5,290
-66
-1% -$2.96K
CAH icon
125
Cardinal Health
CAH
$54.7B
$239K 0.07%
2,140

Similar funds

Vectors Research Management's Q1 2024 Portfolio in Review

As of Q1 2024, Vectors Research Management held 144 positions worth $354M, down 0.26% from $355M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Vectors Research Management withdrew a net $285M in Q1 2024, closing 12 positions and reducing 77 holdings. Its most notable exit was Accenture, an estimated $2.37M position sold in full.

By sector, the portfolio is most concentrated in Technology at 9.5% of assets, up from 9.2% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Vectors Research Management opened a new position in Arcadium Lithium plc worth $579K.

  • Vectors Research Management's largest Q1 2024 buy was Arcadium Lithium plc: 134,450 shares worth $579K.
  • Vectors Research Management added most to Invesco Variable Rate Investment Grade ETF in Q1 2024, an estimated $10.2M increase.
  • Vectors Research Management's biggest Q1 2024 reduction was Eli Lilly, cutting an estimated $96.5M.
  • Vectors Research Management fully exited Accenture in Q1 2024, selling an estimated $2.37M.
  • Vectors Research Management's ten largest holdings make up 42% of its $354M portfolio in Q1 2024.
  • Vectors Research Management opened 4 new positions and closed 12 in Q1 2024.
  • Vectors Research Management's portfolio value fell 0.26% quarter-over-quarter to $354M.

Based on Vectors Research Management's 13F filing for Q1 2024, filed 15 May 2024.